Cargando…
A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients
With the availability of potent antiviral therapies, complete suppression of hepatitis B virus (HBV) replication and total eradication of hepatitis C virus (HCV) can now be achieved. Despite these advances, hepatocellular carcinoma (HCC) still develops in a substantial proportion of cirrhotic patien...
Autores principales: | Huang, Ya-Hui, Liang, Kung-Hao, Chien, Rong-Nan, Hu, Tsung-Hui, Lin, Kwang-Huei, Hsu, Chao-Wei, Lin, Chih-Lang, Pan, Tai-Long, Ke, Po-Yuan, Yeh, Chau-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428873/ https://www.ncbi.nlm.nih.gov/pubmed/28364124 http://dx.doi.org/10.1038/s41598-017-00631-9 |
Ejemplares similares
-
A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
por: Liang, Kung-Hao, et al.
Publicado: (2018) -
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients
por: Liang, Kung-Hao, et al.
Publicado: (2021) -
Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2021) -
Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma
por: Huang, Po-Shuan, et al.
Publicado: (2019) -
Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)